BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28365912)

  • 1. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
    Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease.
    Cai CX; Light JG; Handa JT
    Am J Ophthalmol; 2018 Feb; 186():1-9. PubMed ID: 29126757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ULTRAWIDEFIELD AUTOFLUORESENCE IN ABCA4 STARGARDT DISEASE.
    Klufas MA; Tsui I; Sadda SR; Hosseini H; Schwartz SD
    Retina; 2018 Feb; 38(2):403-415. PubMed ID: 28248825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
    Melillo P; Testa F; Rossi S; Di Iorio V; Orrico A; Auricchio A; Simonelli F
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT247-52. PubMed ID: 27409479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
    Parodi MB; Iacono P; Triolo G; La Spina C; Zucchiatti I; Cicinelli MV; Borrelli E; Manitto MP; Martina E; Bandello F
    Br J Ophthalmol; 2015 Oct; 99(10):1354-9. PubMed ID: 25837607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.
    Gomes NL; Greenstein VC; Carlson JN; Tsang SH; Smith RT; Carr RE; Hood DC; Chang S
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3953-9. PubMed ID: 19324865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morpho-functional analysis of Stargardt Disease for reading.
    Sasso P; Scupola A; Silvestri V; Amore FM; Abed E; Calandriello L; Grimaldi G; Caporossi A
    Can J Ophthalmol; 2017 Jun; 52(3):287-294. PubMed ID: 28576211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
    Sisk RA; Leng T
    Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of multimodal imaging in the various stages of Stargardt disease].
    El Matri L; Falfoul Y; Kortli M; Hassairi A; Charfi H; Turki A; Kort F; Chebil A
    J Fr Ophtalmol; 2017 Oct; 40(8):666-675. PubMed ID: 28919188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of fundus abnormalities in Stargardt disease.
    Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1).
    Burke TR; Rhee DW; Smith RT; Tsang SH; Allikmets R; Chang S; Lazow MA; Hood DC; Greenstein VC
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8006-15. PubMed ID: 21873672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.
    Ritter M; Zotter S; Schmidt WM; Bittner RE; Deak GG; Pircher M; Sacu S; Hitzenberger CK; Schmidt-Erfurth UM;
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6416-25. PubMed ID: 23882696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Disease Progression in Atrophic Age-Related Macular Degeneration and Late-Onset Stargardt Disease.
    Lindner M; Lambertus S; Mauschitz MM; Bax NM; Kersten E; Lüning A; Nadal J; Schmitz-Valckenberg S; Schmid M; Holz FG; Hoyng CB; Fleckenstein M;
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1001-1007. PubMed ID: 28288486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACUTE ZONAL OCCULT OUTER RETINOPATHY: Structural and Functional Analysis Across the Transition Zone Between Healthy and Diseased Retina.
    Duncker T; Lee W; Jiang F; Ramachandran R; Hood DC; Tsang SH; Sparrow JR; Greenstein VC
    Retina; 2018 Jan; 38(1):118-127. PubMed ID: 28590963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13.
    Schönbach EM; Strauss RW; Muñoz B; Wolfson Y; Ibrahim MA; Birch DG; Zrenner E; Sunness JS; Ip MS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2020 Jul; 138(7):772-779. PubMed ID: 32463436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELLIPSOID ZONE MAPPING AND OUTER RETINAL ASSESSMENT IN STARGARDT DISEASE.
    Arepalli S; Traboulsi EI; Ehlers JP
    Retina; 2018 Jul; 38(7):1427-1431. PubMed ID: 28613213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
    Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
    JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared autofluorescence: its relationship to short-wavelength autofluorescence and optical coherence tomography in recessive stargardt disease.
    Greenstein VC; Schuman AD; Lee W; Duncker T; Zernant J; Allikmets R; Hood DC; Sparrow JR
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3226-34. PubMed ID: 26024107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.